Chugai Pharma USA LLC, subsidiary of Chugai Pharmaceutical Co. Ltd., of Tokyo, a member of the Roche Group, named Athos Gianella-Borradori chief medical officer of CPUSA. Read More

Twi Pharmaceuticals Inc., of Tapiei, entered a settlement agreement with Endo Pharmaceuticals Inc., of Malvern, Pa., Teikoku Seiyaku Co. Ltd., of Kagawa, Japan, and Teikoku Pharma USA Inc. to settle outstanding patent litigation related to Twi's lidocaine topical patch 5 percent product. The FDA is reviewing an abbreviated new drug application for Twi's product that, if approved, would be a generic version of Endo's Lidoderm. Read More

HONG KONG – Indian pharmaceutical company Lupin Ltd. (BSE:500257, NSE:LUPIN) plans to launch a new company dedicated to biosimilars in Japan with its Japanese partner, Toyama-based pharmaceutical Yoshindo Inc. Read More

SHANGHAI – Alk-Abello A/S has signed a deal in which up and comer specialty pharmaceutical, Eddingpharm Co. Ltd., will handle the sales and distribution of Alk's allergy immunotherapy treatment here, products it hs been selling under its own steam since 2005. Read More

HONG KONG – An Indian pharmaceutical company said it is still exporting its products to Vietnam as usual, disputing reports that it had been one of some four-dozen companies allegedly banned from the growing Southeast Asian market. Read More

TAIPEI, Taiwan – Taiwan's government-funded Development Center for Biotechnology (DCB) said this week that its mTOR inhibitor cancer drug candidate, DCBCI0901, developed in-house and licensed out in 2011 to an alliance of four local pharmaceutical companies, received approval from the FDA and the TFDA to begin phase I trials. Read More

HONG KONG – One of China's largest vaccine makers will become the first to produce a polio vaccine in China after entering into a deal with a Dutch developer. Read More